dermatology

Laddered treatment for pityriasis rubra pilarisDiagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Switching biologic treatments in dermatologyNot all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.
The experts weigh in on pros and cons of biologicsAccess issues due to cost and availability causes disparities in biologics use; cancer risk is minimal and there is much more on the horizon for hidradenitis suppurativa, researchers say at AAD 2018.
Combination treatment for scars proves effectiveCombination treatments to reduce scarring have been shown to be effective without the need for aggressive surgical techniques that can lead to suboptimal results, researchers reported at AAD 2018 this week.
Skin lupus can progress more rapidly than previously thoughtSystemic disease among patients with discoid lupus erythematosus, a chronic form of cutaneous lupus, can develop within one to two years of initial diagnosis, says Joseph F. Merola, M.D., reporting at the American Academy of Dermatology annual meeting in San Diego.
Biomarkers may predict chronic urticaria resolutionChronic urticaria is associated with a low resolution rate, but researchers writing in JAMA point to biomarkers that may help predict the likelihood of resolution.
Stem cell transplant offers long-term hope for severe scleroderma patientsAn intensive stem cell transplant regimen achieved better survival as compared to cyclophosphamide treatment for patients with severe scleroderma, researchers report in the New England Journal of Medicine.
The February issue of Dermatology Times
The February issue of Dermatology TimesIn this issue of Dermatology Times, we feature pediatric dermatology research, beginning with advances in junctional epidermolysis bullosa that led to the development of new skin for one young patient.
AD therapy linked to ADHDAll children, but healthy controls, had a higher likelihood of behavioral issues. ADHD symptoms of attention, hyperactivity and impulse control, were higher in AD children. Quality of life lower in affected children.